Pharmaceutical Sector

Orchid Gets USFDA Nod For ‘Cefpodoxime’

Orchid_logoIndia's Orchid Chemicals & Pharmaceuticals Ltd has announced that it has received approv

Indo-SA Bilateral Trade Likely To Reach $12 Bn By 2010

New Delhi: Industry body FICCIFICCI President has stated that trade between India and S

BSE Sensex welcomes DLF Limited, kicks out Dr Reddy's Laboratories

DLF Limited BSE Sensex

FDA To Think About Drug Category Between Rx and OTC

FDARockville: The FDA will assemble a public trial by next month to think about formalizing a dispensing g

Ranbaxy Labs is good investment at current levels

As per views of Technical Analysts, Ranbaxy Labs is looking very fairly valued at current market price. The stock ended at 433.10 levels on Friday, down by Rs 9.20 or 2.08%.

Ranbaxy gets USFDA nod for Clarithromycin

Ranbaxy Clarithromycin FDA Pharyngitis

Pages